Cimiracemoside D

CAS No. 290821-39-5

Cimiracemoside D( —— )

Catalog No. M24210 CAS No. 290821-39-5

Cimiracemoside D is a natural product from Cimicifuga foetida L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 141 In Stock
5MG 95 In Stock
10MG 138 In Stock
25MG 227 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cimiracemoside D
  • Note
    Research use only, not for human use.
  • Brief Description
    Cimiracemoside D is a natural product from Cimicifuga foetida L.
  • Description
    Cimiracemoside D is a natural product from Cimicifuga foetida L.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    290821-39-5
  • Formula Weight
    678.86
  • Molecular Formula
    C37H58O11
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[C@]([C@]([C@H](OC(C)=O)C1)([C@]2([H])C3(O[C@@H]4C(C)(O)C)O[C@]4([H])C[C@H]2C)C)([C@H]3O)[C@@](CC[C@@]5([H])C6(C)C)([H])[C@@]71[C@]5(CC[C@@H]6O[C@@](OC[C@H](O)[C@@H]8O)([H])[C@@H]8O)C7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • β II probe

    β II probe

  • Onvatilimab

    Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.

  • Interleukin II (60-7...

    Interleukin II (60-70)